
ãã¯ã€ãããŠã¹ãç»çããCOVIDã¯ã¯ãã³å¿èé害ã®é èœå·¥äœ
å èšäºã¯ãã¡ããã/Click here to read the original article.
DailyCloutãå ¥æããæ å ±å ¬éæ³ã®é»åã¡ãŒã«ã«ããã°ããã¯ã€ãããŠã¹ãçŸç 管çäºé²ã»ã³ã¿ãŒãã¢ã¡ãªã«å°å ç§å»ã¢ã«ãããŒã®é«å®ãã¡ã¯ãCOVID-19ã¯ã¯ãã³ãå¿ççãšæ»äº¡ã«é¢é£ããŠããããšãç¥ã£ãŠããã«ãããããããã¯ã¯ãã³æ¥çš®ãäºéã«çŸ©åä»ããã
ãã¯ã€ãããŠã¹ãšçŸç 管çäºé²ã»ã³ã¿ãŒïŒCDCïŒã¯2021幎4æããã¡ã€ã¶ãŒç€Ÿã®COVID-19 mRNAã¯ã¯ãã³ããã¯ã¯ãã³ãšããŠã¯åäŸã®ãªãèŠæš¡ã®å¿èé害ã«é¢é£ããŠããããšãç¥ã£ãŠãã--ããããæ å ±å ¬éæ³ïŒFOIAïŒã®èŠæ±ãéããŠDailyCloutãå ¥æããé»åã¡ãŒã«ã«ããã°ã圌ãã¯ã¯ã¯ãã³æ¥çš®ã矩åä»ããäžæ¹ã§ããã®ç¥èãåœæ°ããé ããŠããã
ãžã£ãããã»ãŠããã³ãã¯ç±³åœé£åå»è¬åå±ïŒFDAïŒé·å®ïŒåœæïŒããããã¯ã»ããŒã·ãŒç±³åœå€ç§é·å®ããã©ã³ã·ã¹ã»ã³ãªã³ãºç±³åœåœç«è¡çç ç©¶æïŒNIHïŒæé·ïŒåœæïŒã
ãå€ãã®å ¬è¡è¡çã®é«å®ãã¡ããäžå±€éšã®æå°è ãã¡ãšååããŠãCOVID-19 mRNAã¯ã¯ãã³ãšå¿ççãšã®é¢ä¿ãæå°åãã "å¿ççã¡ãŒã« "ãäœæããŸããããšãWar Room/DailyClout Pfizer Documents Analysis Projectã®ããã°ã©ã ã»ãã£ã¬ã¯ã¿ãŒã§ãããšã€ããŒã»ã±ãªãŒã¯è¿°ã¹ãã
ã±ãªãŒæ°ã«ããã°ããã®é¢ä¿è ã¯ä»¥äžã®éãã§ããïŒ COVID-19å¯Ÿå¿æ åœã§ãã¯ã€ãããŠã¹ã®å€§çµ±é ç¹å¥è£äœå®å ŒäžçŽé¡§åå Œã¹ããŒã¯ã¹ãã³ã®ã€ã¢ã³ã»ãµã ã¹æ°ãCDCå ¬è¡è¡çåºç€ã®ã³ãã¥ãã±ãŒã·ã§ã³ã»ãµã€ãšã³ã¹æ åœã¢ãœã·ãšã€ãã»ãã£ã¬ã¯ã¿ãŒïŒåœæïŒã®ã¢ãã²ã€ã«ã»ã¿ã³ãã€æ°ãCDCã®åŠç£å©Šäºé²æ¥ç𮿠åœäž»ä»»ã§CDCã®ä¹³å 転垰ã¢ãã¿ãªã³ã°ç ç©¶ã»äºé²éšé䞻任ã®ããã»ããŒããŒãã«ãã³å士ãªã©ã§ããã
FOIAã®é»åã¡ãŒã«ã¯ãã±ãªãŒãDailyCloutãšWar Roomãããžã§ã¯ãã§ç£ç£ããŠãã250人ã®ãã©ã³ãã£ã¢åŒè·å£«ã®äžäººã§ãããšãã¯ãŒãã»ããŒã³ãããã«ãã£ãŠå ¥æããããã®ã§ããããã®ãããžã§ã¯ãã¯ãè£å€æåœä»€ã§FDAãå ¬éãããã¡ã€ã¶ãŒã®mRNA COVID-19ã¯ã¯ãã³ã«é¢ãã450,000ããŒãžã®èšé²ãã€ãŸã補è¬ã¡ãŒã«ãŒã75幎ééå ¬éã«ããããšããŠå€±æããèšé²ãåæãããã®ã§ããã
War Room-DailyClout Projectã¯ãã¯ãªã³ãã³é£å¶ã®å é¡§åã§ãããã¹ãã»ã©ãŒäœå®¶ã§ãžã£ãŒããªã¹ãã®ããªãã»ãŠã«ããããã©ã³ã倧統é ã®å é¡§åã§ "The War Room "ã®ããããã£ã¹ã¿ãŒã§ããã¹ãã£ãŒãã»ããã³ãšå ±åã§èšç«ããã
ãã©ã³ãã£ã¢ã®åŒè·å£«ã«å ããã±ãªãŒã¯çŽ3250人ã®ãã©ã³ãã£ã¢ã®å»åž«ãçè·åž«ãç§åŠè ããã®ä»ãç£ç£ããææžãæ€èšããŠããã圌ãã¯89ã®èª¿æ»å ±åæžãçºè¡šããŠããããã®äžã«ã¯10æ18æ¥ã«çºè¡šããããFOIAïŒæ å ±å ¬éæ³ïŒã®é»åã¡ãŒã«ã«èŠãããå¿ççã®é èœå·¥äœã«é¢ããå ±åæžãå«ãŸããŠããã
ãé©ãã¹ãããšã«ããã®é»åã¡ãŒã«ã¯ããã¯ã€ãããŠã¹ã«è³ããŸã§ãæäžçŽã®æå°è ãã¡ããmRNAã¯ã¯ãã³ãšé¢é£ããå¿èé害ã«ã€ããŠç¥ã£ãŠããããšãæããã«ããŠããããšã±ãªãŒæ°ã¯èšããããããã圌ã㯠"ãã®å¯äœçšãã¢ã¡ãªã«åœæ°ããé ãããã«èå°è£ã§çµèšããŠãããã
誰ã§ãdailyclout.ioã§3ã€ã®FOIAå ¬éãããé»åã¡ãŒã«ãç ç©¶ããããšãã§ããããšã±ãªãŒã¯èšã£ãã
ãç§ãæãéèŠã ãšæãã®ã¯ã誰ãé¢äžããŠããããèŠãããšã§ãããã¯ã€ãããŠã¹ãCDCãç±³åœä¿å¥ç€ŸäŒçŠç¥çãNIAIDããã¡ã€ã¶ãŒãããã€ãã®å°å ç é¢ãçµç¹ããã®ä»ã®å€éšã®äººã ãªã©ã§ããã
ã±ãªãŒæ°ã«ããã°ããç§ããããèªãã§æããããšã¯ãå ¬è¡è¡çæ©é¢ã®å šå¡ããCOVID-19ã¯ã¯ãã³ã«é¢é£ããå¿ççã®å±éºæ§ã«ã€ããŠãåé¡ãããããšãç¥ã£ãŠãããšããããšã§ããããããé»åã¡ãŒã«ãèªããšããã¯ã€ãããŠã¹ã«è³ããŸã§ãå¿ççãšã¯ã¯ãã³ã®éèŠæ§ã軜èŠããããã«ã¡ãã»ãŒãžãäœæããŠããããšãããããã
ã¡ãŒã«ã«ããã°ãã€ã¹ã©ãšã«ä¿å¥çã¯2021幎2æäžæ¬ã«CDCã«ãã®åé¡ãèŠåããããšããããšã±ãªãŒæ°ã¯èšãã
圌ãã¯ãå¿ççã®ã·ã°ãã«ãèŠããŠããã®ã§ãåãã§æ å ±ãå ±æããŸãããããšèšã£ãã®ã§ããCDCã¯ç§ãç¥ãéããæåã®ã¡ãŒã«ã«è¿äºããããŸããã§ãããããã§ã€ã¹ã©ãšã«ä¿å¥çã¯3æ2æ¥ã«å床ã¡ãŒã«ãéãããå¿ççã®ã·ã°ãã«ããèŠãŠããã
ãã¯ã€ãããŠã¹ã¯17ããŒãžã®å°æ¬ãäœæãã"å šå¡ã«ã¡ãã»ãŒãžãäŒãã "ããã«ãã
ãã¥ãŒãšãŒã¯å·ããã§ã¹ã¿ãŒã®ããŠã³ã¿ãŠã³ã«ããããã«ã»ã¯ãªã¹ãã£ã³ã»ãã§ããŒã·ããæäŒãšã³ãã¥ããã£ã»ã»ã³ã¿ãŒã§ãå»çèªç±éåã®ãªãŒããŒãã¡ãäžå ã«äŒãã "Summit for Truth "ã§ã¯ãFOIAïŒæ å ±å ¬éæ³ïŒã®é»åã¡ãŒã«ã®å±±ãåææ¥ã«ãã°ãã°è©±é¡ãšãªã£ãã
ãŠã«ãã¯ããããŒãã»ãããŒã³å士ãã©ã€ã¢ã³ã»ã³ãŒã«å士ããããŒã»ã¢ã³ã»ã³ãã¯ã¹åŒè·å£«ããã©ãŠã³ã¹ããŒã³ã»ã€ã³ã¹ãã£ãã¥ãŒãã®åºç瀟ã§äœå®¶ã®ãžã§ããªãŒã»ã¿ãã«ãŒæ°ãšãã£ãé¡ã¶ãã®äžã§åºèª¿è¬æŒãè¡ã£ãã
ãŠã«ãã¯ãCOVID-19泚å°ã®å®å šæ§ã«çåãåããããšã§ããã§ããã¹ãã®è±¡åŸŽãããªãã©ã«ãªã¡ãã£ã¢äœå¶ããã®ãè ã«ããããŸã§ã®éã®ãã«ã€ããŠèªã£ãã
圌女ã¯ãã³ãããã¯ã®èª¿æ»ã»å ±éã®çµéšã«ã€ããŠ2åã®æ¬ãæžããŠããããã®ãã¡ã®äžåããThe Bodies of Othersãã§ããïŒ The New Authoritarians, COVID-19 and the War Against the Human"ïŒæ°ããæš©åšäž»çŸ©è ãã¡ãCOVID-19ããããŠäººéãšã®æŠãïŒããããŠè¿åã® "Facing the Beast"ïŒéç£ã«ç«ã¡åããïŒã§ããïŒ Courage, Faith, and Resistance in a New Dark Age"ïŒåæ°ãä¿¡ä»°ããããŠæ°ããªæé»æä»£ã«ãããæµæïŒãªã©ã§ããã
åææ¥ã®ããã«ãã£ã¹ã«ãã·ã§ã³ã§ããŠã«ãã¯ã¯ã¯ãã³ã®å±éºæ§ã®é èœã«ãã¯ã€ãããŠã¹ãé¢äžããŠããããšã "ãŸã£ããã·ã§ããã³ã°ãªããšã "ãšè¿°ã¹ãã
ããŒã³ãããã®æ å ±å ¬éè«æ±ã¯ã"CDCã®å éšåçºè "ã«å©ããããã
圌ãèŠæ±ããããŒãžã«å ããŠããã¯ã€ãããŠã¹ã®åºå ±ããŒã ãã2021幎4æãè¡æ ãšå¿èæå·ã®ãã¥ãŒã¹ãå±ãããããæé«ã¬ãã«ã§ãããã¯ã«ãªã£ãŠããããšã瀺ããèŠæ±ããŠããªã46ããŒãžãåŸããããããšãŠã«ãã¯èšã£ãã
ãã¢ã¡ãªã«åœæ°ã«çœç¶ãããã®æ³šå°ãåžå Žããæ€éããã代ããã«ã圌ãã¯ãã¡ãŠãå士ãã³ãªã³ãºå士ãã¯ã¬ã³ã¹ããŒå士ãå·»ã蟌ã¿ãå°æ¬ãäœæãããã
ãã®å°æ¬ã¯17ããŒãžã«ãåã³ããã®å 容ã¯ãã¹ãŠç·šéãããŠãããå®éã2021幎ã®ããšãæãåºããŠã»ãããã圌ãã¯ãã®æ³šå°ãåžå Žããæ€éãããã©ãããã矩ååããã®ã ãåå¢ããŠçŸ©ååããã®ã ã
ãŠã«ãã¯ãé»åã¡ãŒã«ã¯ "å€§èŠæš¡ãªç¯çœª "ãæããã«ããŠãããšè¿°ã¹ãã
å¿ççãšã¯ã¯ãã³ã«é¢ããç±³åœå ¬è¡è¡çåœå±ã®ãããå士ã®é»åã¡ãŒã«ã§ã®è°è«ã«ã€ããŠå€§çµ±é ã«ææ°æ å ±ãæäŸããããã«ã"POTUSïŒç±³åœå€§çµ±é ãæå³ããïŒ"ã«é»åã¡ãŒã«ãéãããã®ãã³ãã¬ãŒããçšæãããŠããããšãŠã«ãã¯èšãã
ããŠã©ã¬ã³ã¹ããŒå士ãããã¡ãŠãå士ããã³ãªã³ãºå士ãã¡ãŒã«ã«ç»å ŽããŸããããã¯ã€ãããŠã¹ã®åºå ±ããŒã å šäœãè°è«ãé²ããŠãããã
ã圌ãã¯ãè¡æ ãå¿èãžã®ãã¡ãŒãžãå€§èŠæš¡ã«æç€ºãããã¢ã¡ãªã«å°å ç§åŠäŒã10代ã®è¥è ã®å¿ççã«ã€ããŠèŠåããŠããäºå®ã«åå¿ããŠãããããããã¢ã¡ãªã«åœæ°ã«æœçœã瀺ã代ããã«......äºã®è¶³ãèžãã§ãé èœããäœæŠã«åºãã®ã ã
å ¬è¡è¡çåœå±ã¯ããã€ã¶ãŒCOVID-19ã¯ã¯ãã³ã®æ¥çš®ã矩åã¥ãããããã人ã ãæ®ºããŠããããšãç¥ããªãããé²ããããšãŠã«ãã¯èšãã
ããŒã¿ãŒã»ããã«ããŒå士ã¯ãäžçã§æãå€ãã®è«æãçºè¡šããŠããå¿èå°éå»ã®äžäººã§ããããã¡ã€ã¶ãŒç€Ÿã®COVID-19ã¯ã¯ãã³ã¯ãçç©åŠç補å€ã®å®å šæ§ãä¿èšŒããåŸæ¥ã®æ¿åºåºæºã§ãããæ»äº¡è æ°50人以äžãã®åŸã2021幎1æã«åžå Žããæ€å»ãããã¹ãã ã£ãããšè¿°ã¹ãã
ããã«ããŒã«ããã°ãFDAã®èšé²ã«ããã°ãFDAã¯2020幎10æ22æ¥ã®æç¹ã§mRNA COVID-19ã¯ã¯ãã³ã«ããå¿ççãªã¹ã¯ãäºæž¬ããŠããã
ããããçŽ2ãµæåŸããã¡ã€ã¶ãŒç€Ÿã¯2020幎12æ10æ¥ã®FDAã¯ã¯ãã³ããã³é¢é£çç©åŠç補å€è«®åå§å¡äŒã®åã«ãèªç€Ÿã®ã¯ã¯ãã³ã«é¢é£ãã38ä»¶ã®æ»äº¡äŸããé èœãããã
ããã圌ãããããã®æ»äº¡ãå ±åããŠããã°ã2020幎12æ10æ¥ã®äŒè°ã®ã³ã¢ã¹ã©ã€ãã«ãããã¡ã€ã¶ãŒç€Ÿã®å¿è¡ç®¡ç³»ãªã¹ã¯ã¯3åãã4åéå°ãšãªãããã¡ã€ã¶ãŒç€Ÿã¯æ¿èªãããªãã£ãã ããããšåœŒã¯è¿°ã¹ãã
ããã«ããŒæ°ã¯ããå¿ççã®é èœå·¥äœãäœå人ãã®ã¢ã¡ãªã«äººã殺ããããšè¿°ã¹ãã
圌ã¯ããŠã£ãªã¢ã ã»ããã¹å士ãå«ãä»ã®ç§åŠè ãã¡ãšã®ç ç©¶è«æãææããã圌ãã¯2023幎7æ3æ¥ãŸã§ã«ãCOVID-19ã¯ã¯ãã³æ¥çš®ã«é¢é£ããå¿ççã«é¢ãããã¹ãŠã®çºè¡šãããåæ€å ±åãã®ã·ã¹ãããã£ãã¯ã»ã¬ãã¥ãŒãè¡ã£ãã
ãã®çµæããã¯ã¯ãã³æ¥çš®è ã«äºæãã¬çªç¶æ»ãèµ·ãã£ãã±ãŒã¹ã§ã¯ãCOVID-19ã¯ã¯ãã³ãšå¿ççãçãããæ»äº¡ãšã®éã«å æé¢ä¿ãããå¯èœæ§ãé«ã ããšçµè«ã¥ããã
McCulloughæ°ãã¯ããèŽæ»çãªCOVID-19ã¯ã¯ãã³èªçºå¿ççã®éå£çºçãæžå°ãããããã«ããªã¹ã¯å±€å¥åãšè»œæžãç®çãšããç·æ¥èª¿æ»ãå¿ èŠã§ãã ããšçµè«ã¥ããã
ãããªãå·ããŒãŠãšã¹ãã®åŸªç°åšå°éå»ã§ãããã«ãŒã¹ã»ããã¹å士ã¯ãæ°ããæç®ã®ç ç©¶ã«åºã¥ããŠãCOVID-19ã®æ©ææ²»çã«ã€ãã«ã¡ã¯ãã³ã䜿çšããæåã®ã¢ã¡ãªã«äººå»åž«ã®äžäººã§ããããæè¿ã®ç ç©¶ã¯COVID-19ã¯ã¯ãã³ã®RNAã "å¿èã«çŽæ¥äœçšãã "ããšã瀺ããŠãããšè¿°ã¹ãã
ã¢ãããšãã¡ã€ã¶ãŒã®ã¯ã¯ãã³ãå¹é€äžã®å¿ç现èã«é©çšããç ç©¶ã§ã¯ãã48æé以å ã«å¿èã®æ©èœéå®³ãæ©æ¢°çã黿°çæ··ä¹±ãçãããšããçŽæ¥çãªèšŒæ ã瀺ãããŸããããšããã¹æ°ã¯è¿°ã¹ãã
å¿äžå šã§æ»äº¡ããè¥ãã¢ã¹ãªãŒãã¯ãåäŸããªãã»ã©å€ããäºé²æ³šå°ã«ãã£ãŠåŒãèµ·ããããå¿ççã®çç¶ã« ãã»ãŒééããªãèŠããã§ãã ããšåœŒã¯èšãã
ããã®æ³šå°ãåãã人ã¯å šå¡ãå¿çã«äœããã®ãã¡ãŒãžãåããŠããŸãããã圌ãã¯åèšåºè©Šéšã§ãããç¥ã£ãŠããã®ã«ãé èœããã®ã§ãããã¹ãŠã®ã·ã°ãã«ããã£ãã®ã«ãFDAã¯ãããæ¿èªãããã
ããã¹ãŠã¯ãããŒã²ãŒã ã§ãããåªçåŠã²ãŒã ã§ããã圌ãã¯ããŒã¹ã¿ãŒãå¿ èŠã ãšèšãç¶ããŠããã®ã§ããä»ãäžçäžã®ãã¹ãŠã®åäŸãã¡ããå±éºã§ãããã®ããã«èª€èªãããŠãããŠã€ã«ã¹ã®äºé²æ¥çš®ãåããªããã°ãªããªããã
ãæ²ãããªããŸãããšããã¹æ°ã¯ç· ãããã£ãããç§ãã¡ã¯ããããçç©å µåšãšããŠäœãããããšãæãåºããæ¿åºã®è²¬ä»»ã远åããå¿ èŠããããŸãã